Data analysis reveals a stable, cross-cohort female cancer mortality excess at ages 35-60, contrasting with female advantages in cardiovascular and external-cause mortality. Breast cancer drives the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results